Verastem, Inc. - stock earnings
VSTM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -20.0 million USD | ? USD |
| 2023Q2 | -24.3 million USD | ? USD |
| 2023Q1 | -12.9 million USD | ? USD |
| 2022Q4 | -16.8 million USD | 2.6 million USD |
| 2022Q3 | -18.1 million USD | ? USD |
| 2022Q2 | -22.0 million USD | ? USD |
| 2022Q1 | -17.0 million USD | 2.6 million USD |
| 2021Q4 | -16.5 million USD | 545000 USD |
| 2021Q3 | -22.8 million USD | 2000 USD |
| 2021Q2 | -16.9 million USD | 500000 USD |
| 2021Q1 | -15.0 million USD | 1.0 million USD |
| 2020Q4 | -19.9 million USD | 506000 USD |
| 2020Q3 | 13.1 million USD | 78.6 million USD |
| 2020Q2 | -23.0 million USD | 4.3 million USD |
| 2020Q1 | -38.0 million USD | 5.1 million USD |
| 2019Q4 | -38.8 million USD | 3.6 million USD |
| 2019Q3 | -30.1 million USD | 9.0 million USD |
| 2019Q2 | -42.2 million USD | 3.1 million USD |
| 2019Q1 | -38.1 million USD | 1.7 million USD |
| 2018Q4 | -11.3 million USD | 1.2 million USD |
| 2018Q3 | -21.7 million USD | 15.5 million USD |
| 2018Q2 | -18.4 million USD | 10.0 million USD |
| 2018Q1 | -21.1 million USD | ? USD |
| 2017Q4 | -18.2 million USD | ? USD |
| 2017Q3 | -23.1 million USD | ? USD |
| 2017Q2 | -13.4 million USD | ? USD |
| 2017Q1 | -13.0 million USD | ? USD |
| 2016Q4 | -11.7 million USD | ? USD |
| 2016Q3 | -7.9 million USD | ? USD |
| 2016Q2 | -8.6 million USD | ? USD |
| 2016Q1 | -8.3 million USD | ? USD |
| 2015Q4 | -11.9 million USD | ? USD |
| 2015Q3 | -15.4 million USD | ? USD |
| 2015Q2 | -15.4 million USD | ? USD |
| 2015Q1 | -15.2 million USD | ? USD |
| 2014Q4 | -13.9 million USD | ? USD |
| 2014Q3 | -13.3 million USD | ? USD |
| 2014Q2 | -13.0 million USD | ? USD |
| 2014Q1 | -13.1 million USD | ? USD |
| 2013Q4 | -11.3 million USD | ? USD |
| 2013Q3 | -10.6 million USD | ? USD |
| 2013Q2 | -10.3 million USD | ? USD |
| 2013Q1 | -9.0 million USD | ? USD |
| 2012Q4 | -7.9 million USD | ? USD |
| 2012Q3 | -10.4 million USD | ? USD |
| 2012Q2 | -6.8 million USD | ? USD |
| 2012Q1 | -6.9 million USD | ? USD |
| 2011Q4 | -6.0 million USD | ? USD |
| 2011Q3 | -4.0 million USD | ? USD |
| 2011Q2 | -2.5 million USD | ? USD |
| 2011Q1 | -1.1 million USD | ? USD |
VSTM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -76.8 million USD | ? USD |
| 2022 | -73.8 million USD | 2.6 million USD |
| 2021 | -81.1 million USD | 2.1 million USD |
| 2020 | -67.7 million USD | 88.5 million USD |
| 2019 | -169.2 million USD | 17.5 million USD |
| 2018 | -72.4 million USD | 26.7 million USD |
| 2017 | -67.8 million USD | ? USD |
| 2016 | -36.4 million USD | ? USD |
| 2015 | -57.9 million USD | ? USD |
| 2014 | -53.4 million USD | ? USD |
| 2013 | -41.2 million USD | ? USD |
| 2012 | -32.0 million USD | ? USD |
| 2011 | -13.7 million USD | ? USD |
VSTM
Price: $10.90
52 week price:
Earnings Per Share: -3.96 USD
P/E Ratio: -3.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 245000
Ebitda: -22.9 millionMarket Capitalization: 297.0 million